ThyX inhibitors (Tydockpharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameThyX inhibitors (Tydockpharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsHelicobacter pylori infectionTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTydock Pharma Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTydock Pharma Srl
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infectionTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A